Journal article
Mass drug administration for the acceleration of malaria elimination in a region of Myanmar with artemisinin-resistant falciparum malaria: a cluster-randomised trial
- Abstract:
-
Background: To contain multidrug-resistant Plasmodium falciparum, malaria elimination in the Greater Mekong subregion needs to be accelerated while current antimalarials remain effective. We evaluated the safety, effectiveness, and potential resistance selection of dihydroartemisinin–piperaquine mass drug administration (MDA) in a region with artemisinin resistance in Myanmar.
Methods: We did a cluster-randomised controlled trial in rural communi...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 2.7MB, Terms of use)
-
- Publisher copy:
- 10.1016/s1473-3099(20)30997-x
Authors
- Publisher:
- Elsevier
- Journal:
- Lancet Infectious Diseases More from this journal
- Volume:
- 21
- Issue:
- 11
- Pages:
- 1579-1589
- Place of publication:
- United States
- Publication date:
- 2021-06-18
- Acceptance date:
- 2020-12-17
- DOI:
- EISSN:
-
1474-4457
- ISSN:
-
1473-3099
- Pmid:
-
34147154
- Language:
-
English
- Keywords:
- Pubs id:
-
1183070
- Local pid:
-
pubs:1183070
- Deposit date:
-
2023-11-17
- ARK identifier:
Terms of use
- Copyright holder:
- Elsevier
- Copyright date:
- 2021
- Rights statement:
- © 2021 Elsevier Ltd. All rights reserved.
- Notes:
- This is the accepted manuscript version of the article. The final version is available online from Elsevier at https://dx.doi.org/10.1016/s1473-3099(20)30997-x
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record